Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
Quick Stats
Jan 30, 202662.0
AI Score
BUY1.01
Volume Ratio
Feb 11, 2026
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
NBIX Stock Summary
Last updated Jan 30, 2026
NBIX is currently trading at $136.06, positioned above its 200-day moving average of $133.98, indicating a long-term uptrend. The stock has a 52-week range of $84.23 to $160.18.
Technical Analysis: The 50-day moving average stands at $142.75, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 46.04, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.033, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NBIX at 62.0/100 with a BUY recommendation.
NBIX (Neurocrine Biosciences Inc) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 46.04 |
| CMF (20) | -0.033 |
| ROC (10) | 2.032 |
| ADX (14) | 20.85 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -2.028 |
| AROONOSC (14) | 21.429 |
| WILLAMS %R (14) | -27.969 |
| MFI (14) | 48.414 |
NBIX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NBIX Price vs Max Options Open Interest
NBIX Max Change In Options Open Interest
NBIX Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NBIX Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NBIX Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NBIX Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Neurocrine Biosciences Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
NBIX Moving Averages Analysis
Neurocrine Biosciences Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
NBIX (Neurocrine Biosciences Inc) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 135.31 |
| 20 | 135.63 |
| 30 | 138.53 |
| 50 | 142.75 |
| 100 | 142.69 |
| 200 | 133.98 |
NBIX Fundamental Analysis
| P/E (Forward) | 18.7266 |
| P/E (Trailing) | 32.1384 |
| Market Cap ($) | 13.4 billion |
| Earnings/Share ($) | 4.19 |
| Net Proft Margin (%) | 0.1595 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 6.8607 |
| EPS Estimate Next Year ($) | 9.1914 |
| WallStreet Target Price ($) | 179.2559 |
| Most Recent Quarter |